Heat shock protein 90 inhibitor AUY922 attenuates platelet-derived growth factor-BB-induced migration and proliferation of vascular smooth muscle cells
- 주제(키워드) Atherosclerosis , AUY922 , Heat shock protein 90 , Platelet-derived growth factor , Vascular disease
- 주제(기타) Pharmacology & Pharmacy
- 주제(기타) Physiology
- 설명문(일반) [Kim, Jisu] Konkuk Univ, Dept Sports Med & Sci Grad Sch, Seoul 05029, South Korea; [Lee, Kang Pa; Baek, Suji] UMUST R&D Corp, Res & Dev Ctr, Seoul 05029, South Korea; [Kim, Born Sahn; Moon, Byung Seok] Ewha Womans Univ, Coll Med, Dept Nucl Med, Seoul Hosp, Seoul 07804, South Korea; [Lee, Sang Ju] Univ Ulsan, Dept Nucl Med, Coll Med, Asan Med Ctr, Seoul 05505, South Korea
- 등재 SCIE, SCOPUS, KCI등재
- OA유형 Green Published, gold
- 발행기관 KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- 발행년도 2020
- 총서유형 Journal
- URI http://www.dcollection.net/handler/ewha/000000169300
- 본문언어 영어
- Published As https://dx.doi.org/10.4196/kjpp.2020.24.3.241
초록/요약
Luminespib (AUY922), a heat shock proteins 90 inhibitor, has anti-neoplastic and antitumor effects. However, it is not clear whether AUY922 affects events in vascular diseases. We investigated the effects of AUY922 on the platelet-derived growth factor (PDGF)-BB-stimulated proliferation and migration of vascular smooth muscle cells (VSMC). VSMC viability was detected using the XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) reagent. To detect the attenuating effects of AUY922 on PDGF-BB-induced VSMCs migration in vitro, we performed the Boyden chamber and scratch wound healing assays. To identify AUY922-mediated changes in the signaling pathway, the phosphorylation of protein kinase B (Akt) and extracellular signal-regulated kinase (ERK) 1/2 was analyzed by immunoblotting. The inhibitory effects of AUY922 on migration and proliferation ex vivo were tested using an aortic ring assay. AUY922 was not cytotoxic at concentrations up to 5 nM. PDGF-BB-induced VSMC proliferation, migration, and sprout outgrowth were significantly decreased by AUY922 in a dose-dependent manner. AUY922 significantly reduced the PDGF-BB-stimulated phosphorylation of Akt and ERK1/2. Furthermore, PD98059 (a selective ERK1/2 inhibitor) and LY294002 (a selective Akt inhibitor) decreased VSMC migration and proliferation by inhibiting phosphorylation of Akt and ERK1/2. Greater attenuation of PDGF-BB-induced cell viability and migration was observed upon treatment with PD98059 or LY294002 in combination with AUY922. AUY922 showed anti-proliferation and anti-migration effects towards PDGF-BB-induced VSMCs by regulating the phosphorylation of ERK1/2 and Akt. Thus, AUY922 is a candidate for the treatment of atherosclerosis and restenosis.
more